139 related articles for article (PubMed ID: 38224863)
1. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
2. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
3. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
4. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Cheng X; Li M; Rao X; Zhang W; Li X; Wang L; Huang G
Onco Targets Ther; 2019; 12():3421-3428. PubMed ID: 31118692
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.
Liu H; Lan T; Li H; Xu L; Chen X; Liao H; Chen X; Du J; Cai Y; Wang J; Li X; Huang J; Yuan K; Zeng Y
Theranostics; 2021; 11(3):1396-1411. PubMed ID: 33391541
[No Abstract] [Full Text] [Related]
6. KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification.
Kuang Y; Cheng Y; Wang J; Li H; Cao X; Wang Y
Cancer Med; 2023 Mar; 12(6):7222-7233. PubMed ID: 36420693
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP; Huang XY
Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
[TBL] [Abstract][Full Text] [Related]
8. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
[TBL] [Abstract][Full Text] [Related]
9. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
[TBL] [Abstract][Full Text] [Related]
10. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
[TBL] [Abstract][Full Text] [Related]
11. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
12. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
13. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.
Liu B; Cao J; Wu B; Hao K; Wang X; Chen X; Shen Z
Cell Commun Signal; 2023 May; 21(1):121. PubMed ID: 37231451
[TBL] [Abstract][Full Text] [Related]
14. KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN.
Meng Y; Yang W; Li J; Chai W
Heliyon; 2023 Nov; 9(11):e22084. PubMed ID: 38058614
[TBL] [Abstract][Full Text] [Related]
15. KIAA1429 Promotes Nasopharyngeal Carcinoma Progression by Mediating m6A Modification of PTGS2.
Wu L; Zhou Y; Fu J
Crit Rev Immunol; 2023; 43(4):15-27. PubMed ID: 37830191
[TBL] [Abstract][Full Text] [Related]
16. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
Chen X; Fan R
J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
[TBL] [Abstract][Full Text] [Related]
17. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
18. KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m
Wang H; Chen W; Cui Y; Gong H; Li H
J Cell Mol Med; 2023 Dec; 27(24):4118-4132. PubMed ID: 37830241
[TBL] [Abstract][Full Text] [Related]
19. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
20. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m
Wang M; Yang Y; Yang J; Yang J; Han S
Life Sci; 2020 Sep; 257():118082. PubMed ID: 32653519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]